Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro

Human Reproduction

Volumn 24, Issue 9, 2009, Pages 2187-2192

  Klemmt, Petra A B ^a,b   Liu, Fang ^a   Carver, Janet G ^a   Jones, Celine ^a   Brosi, Dorothea ^a   Adamson, Jonathan ^a   Mardon, Helen J ^a   McVeigh, Enda ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b Institute for Biomedical Research   (Germany)

Author keywords

Blastocyst invasion; Endometrium; GnRH analogues

Indexed keywords

BUSERELIN; CETRORELIX; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; METHYLTESTOSTERONE;

ADULT; ARTICLE; BLASTOCYST; CELL INVASION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DECIDUALIZATION; DRUG EFFECT; EMBRYO; ENDOMETRIUM; ENDOMETRIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FERTILE PERIOD; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NIDATION; PROTEIN EXPRESSION; STROMA CELL; TROPHOBLAST;

ADULT; BUSERELIN; DECIDUA; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVULATION INDUCTION; RECEPTORS, LHRH; STROMAL CELLS;

EID: 68949201647     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep181     Document Type: Article

References (21)

1. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2006;3:CD001750.
2. Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update 2003;9:515-522.
3. Carver J, Martin K, Spyropoulou I, Barlow D, Sargent I, Mardon H. An in-vitro model for stromal invasion during implantation of the human blastocyst. Hum Reprod 2003;18:283-290.
4. Casan EM, Raga F, Bonilla-Musoles F, Polan ML. Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation. J Clin Endocrinol Metab 2000;85:1377-1381.
5. Cheng CK, Leung PC. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 2005;26:283-306.
6. Chobotova K, Muchmore ME, Carver J, Yoo HJ, Manek S, Gullick WJ, Barlow DH, Mardon HJ. The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha. J Clin Endocrinol Metab 2002;87:5769-5777.
7. Choi YS, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients. Hum Reprod 2006;21:2015-2021.
8. Chou CS, Tai CJ, MacCalman CD, Leung PC. Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinases-1 messenger ribonucleic acid levels in human decidual Stromal cells in vitro. J Clin Endocrinol Metab 2003;88:680-688.
9. Ferrari B, Pezzuto A, Barusi L, Coppola F. Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles. Eur J Obstet Gynecol Reprod Biol 2006;124:70-76.
10. Greisinger G, Diedrich K, Devroey P, Kolibinianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta- analysis. Hum Reprod Update 2006;12:159-168.
11. Kawamura K, Fukuda J, Kumagai J, Shimizu Y, Kodama H, Nakamura A, Tanaka T. Gonadotropin-releasing hormone I analog acts as an antiapoptotic factor in mouse blastocysts. Endocrinology 2005; 146:4105-4116.
12. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril 2006; 85:564-572.
13. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, Itskovitz-Eldor J. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 1999;14:2242-2244.
14. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update 2006;12:3-12.
15. Macklon NS, Fauser BC. Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil Suppl 2000;55:101-108.
16. Meresman GF, Bilotas MA, Lombardi E, Tesone M, Sueldo C, Baranao RI. Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 2003;18:1767-1771.
17. Papanikolaou EG, Camus M, Fatemi HM, Tournaye H, Verheyen G Van Steirteghem A, Devroey P. Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. Reprod Biomed Online 2006;12:60-65.
18. Shemesh M. Actions of gonadotrophins on the uterus. Reproduction 2001; 121:835-842.
19. Takeuchi S, Futamura N, Minoura H, Toyoda N. Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua. Life Sci 1998;62:1187-1194.
20. Torres Mde M, Donadio N, Donadio NF, Brandao AC, Heck B. Comparison of embryo implantation in Wistar rats that underwent ovarian stimulation using exogenous gonadotropins associated with cetrorelix acetate or leuprolide acetate. Fertil Steril 2005;84:1235-1240.
21. Zikopoulos K, Kolibianakis EM, Camus M, Tournaye H, Van den Abbeel E, Joris H, Van Steirteghem A, Devroey P. Duration of gonadotropinreleasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. Fertil Steril 2004;81:473-475.